Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?

Front Neurol. 2023 Mar 10:14:1134691. doi: 10.3389/fneur.2023.1134691. eCollection 2023.

Collaborative Working Group:
Roberto Antonacci, Fabrizio Balestrieri, Marco Battaglia, Luciano Bissolotti, Margherita Borg, Marcello Campagnoli, Anna Castagna, Carmelo Chisari, Nicoletta Cinone, Claudio Corradini, Michela Cosma, Davide Dalla Costa, Paolo De Blasiis, Alessandra Del Felice, Giovanni Morone, Antonio Robecchi Majnardi, Francesco Sciarrini, Alessandro Specchia, Carlo Trompetto

¹ Department of Health Sciences, Università del Piemonte Orientale, Physical Medicine and Rehabilitation, Maggiore della Carità University Hospital, Novara, Italy.
² Physical Medicine and Rehabilitation, ASST Settelaghi, Varese, Italy.
³ Physical Medicine and Rehabilitation, Policlinico Hospital, Università di Foggia, Foggia, Italy.
⁴ Department of Neurology, ASST Fatebenefratelli-Sacco, Milan, Italy.
⁵ Villa Beretta Rehabilitation Center, Valduce Hospital, Costa Masnaga, Italy.
⁶ Neuromotor and Cognitive Rehabilitation Study and Research Centre, Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, Verona, Italy.

No abstract available

Keywords: adjunctive treatment; botulinum toxin type A; rehabilitation; spasticity; stroke.